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Abstract - In this study, twelve strains of Lactobacillus plantarum derived from spontaneously fermented vegetables (car-
rots and beetroot) and traditionally prepared sauerkraut were compared for their potential probiotic abilities with seven 
Lactobacillus rhamnosus strains of human origin. The tested strains were investigated for some technological properties 
and in vitro functional characteristics for potential probiotic strains. Selection probiotic criteria included the ability of 
the strains to withstand conditions similar to the digestive tract, antimicrobial activity against a wide range of intestinal 
pathogens and sensitivity to antibiotics. The total acidity in milk was generally higher in intestinal strains in relation to 
plant strains. The ability of the tested strains to survive simulated gastric conditions showed a greater resistance of the hu-
man strains at a low pH 2.5 and the presence of pepsin, while in the presence of bile salts and pancreatin, some intestinal 
strains were more sensitive compared to plant strains. A wide spectrum of antimicrobial activities was observed in all 
tested strains. Most of the plant strains were resistant to aminoglycosides and vancomycin but sensitive to ampicillin and 
penicillin, while only some intestinal strains were resistant to these drugs.
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INTRODUCTION
Probiotic refers to live microorganisms which, when 
administrated in adequate amounts, confer a health 
benefit on the host (FAO, 2006). The health benefits 
associated with the ingestion of probiotic bacteria 
include a reduction in colon irritation and constipa-
tion, treatment of acute rotavirus diarrhea, inhibition 
antagonism towards intestinal pathogens, synthesis 
of B vitamins, lactose maldigestion, cholesterol ab-
sorption and inhibition of tumor formation (Ziemer 
and Gibson, 1998). 
In order to provide health benefits, probiotic 
strains must overcome physical and chemical barri-
ers in the gastrointestinal tract, especially acid and 
bile stresses (Del Piano et al., 2006). The absence of 
pathogenicity, the ability to adhere to the gastroin-
testinal mucosa and the competitive exclusion of 
pathogens are also criteria that have been used for 
the selection of probiotics (Ouwehand et al., 2004). 
The mechanism through which probiotics may an-
tagonize pathogens involves the production of anti-
microbial compounds such as lactic acid, acetic acid, 
hydrogen peroxide and bacteriocins. 
Although Lactobacillus spp. have GRAS (gener-
ally recognized as safe) status, because of their long 
and safe use in food fermentation, it is necessary 
to confirm the safety of these microorganisms in-
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tended for use in food production. There is serious 
concern as to the resistance of probiotic bacteria to 
antibiotics. Thus, one of the crucial criteria in the 
selection of potential probiotics is their sensitiv-
ity to antibiotics. Probiotic bacteria as well as LAB 
used in food, may have antibiotic-resistance genes, 
which can be transferred to pathogenic bacteria 
that occur in the gastrointestinal tract (Radulović 
et al., 2012).
There is growing interest in the utilization of 
Lactobacillus strains isolated from both traditional 
fermented products and humans for their health-
promoting effects. Some Lactobacillus strains occur 
naturally in the human intestine. For this reason 
such intestinal microorganisms are also preferen-
tially developed for commercial use as probiotics. 
A better resistance of strains of human origin in 
simulated gastrointestinal conditions compared to 
strains of dairy origin has been reported (Prasad et 
al., 1999). However, Haller et al. (2001) showed that 
the metabolic and functional properties of intes-
tinal lactobacilli are also found in certain bacteria 
originating in fermented foods. Additionally, simi-
lar immunoenhancing properties were described 
for strains independent of their origin (Dogi and 
Perdigón, 2006). 
The aim of this work was to compare the poten-
tial probiotic ability among lactobacilli derived from 
different fermented vegetables with human-derived 
lactobacilli. The probiotic properties were comprised 
of their sensitivity to simulated gastrointestinal tract 
conditions, antimicrobial activity against a wide 
range of pathogens and antibiotic resistance. 
MATERIALS AND METHODS
Bacterial cultures
Twelve autochthonous Lactobacillus plantarum 
strains isolated from various fermented vegeta-
bles (data not published) and seven Lactobacillus 
rhamnosus strains derived from preterm infants 
(Bogićević, 2009) were used for examination (Table 
1). The strains from fermented vegetables belong to 
the strains collection of the Department of Indus-
trial Microbiology, Faculty of Agriculture, University 
of Belgrade, while the human strains belong to the 
strains collection of the Department of Biochemical 
Engineering and Biotechnology, Faculty of Technol-
ogy and Metallurgy, University of Belgrade. The test-
ed strains were maintained as a frozen stock at -20°C 
in Man Rogosa Sharpe (MRS) broth containing 20% 
(v/v) glycerol, propagated twice in MRS broth at 
30°C before use.
Technological characteristics of the strains
The examination of the tested strains for potential 
application in food production was performed by 
testing some technological properties: growth at 
different temperatures (15, 30, 45°C) and survival 
at 60°C, growth in milk, growth in litmus milk and 
production of lactic acid. 
Tolerance to simulated gastrointestinal conditions 
(gastric and bile salts test)
Sensitivity to simulated gastrointestinal tract con-
ditions has been tested as described by Doleyres et 
al. (2004), with certain modification. Briefly, sur-
vival of the tested strains in gastric conditions was 
performed at a low pH 2.5 in the presence of pep-
sin (0.3%) after 30 min incubation at 37ºC, and for 
duodenal conditions, cell survival in the presence of 
0.4% bile salts and 0.2% pancreatin after 60 min in-
cubation at 37ºC.
Antimicrobial activity
The antimicrobial activity of the tested plant and 
human strains was screened using the spot method 
as described by Bernet et al. (1993). The antimicro-
bial activities were tested against a range of intesti-
nal pathogens: Bacillus subtilis ATCC 6633, Can-
dida albicans ATCC 24433, Salmonella enteritidis 
ATCC 31806, Staphylococcus aureus ATCC 25923, 
Escherichia coli ATCC 25922 and Listeria monocy-
togenes ATCC 19115. The antibacterial activity was 
related to the inhibition clear zone, which was cal-
culated as the difference between the total of inhibi-
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tion zone and the diameter of the growth spot of the 
indicator strains.
Antibiotic resistance
The antibiotic resistance patterns of the tested 
plant and human strains were determined by 
the disk diffusion method on an MRS agar plate 
(Bauer et al., 1966). A total of 12 antibiotic sub-
stances were tested: tetracycline, chloramphenicol, 
streptomycin, neomycin, penicillin, ampicillin, 
kanamycin, trimethoprim-sulfamethoxazole, van-
comycin, rifampin, gentamicin and doxycycline 
(Torlak, Serbia). MRS agar plates were overlaid 
with 6 ml of top MRS agar (0.6% of agar) inocu-
lated with 0.2 ml of tested lactobacilli. After the 
top MRS agar hardened, the disks with antibiotics 
were dispensed onto the plates and incubated un-
der anaerobic condition at 37°C for 24 h. The di-
ameter (mm) of the inhibition zone was measured 
and the mean of two observations was expressed in 
terms of resistant (R), moderately susceptible (MS) 
and susceptible (S). 
RESULTS AND DISCUSSION
Sensitivity to some technological characteristics
Comparing the growth at different temperatures, it 
was observed that all the isolates from fermented 
vegetables grew at 15 and 30°C, while two human 
isolates, TMFM and TMFV, showed an ability to 
grow at 45°C as well as to survive at 60°C (Table 1), 
which proved them to be good candidates for food 
application. 
The total acidity in milk was generally higher in 
the intestinal L. rhamnosus strains in relation to L. 
plantarum strains from fermented vegetables, while 
all tested isolates showed coagulation, acidification 
and reduction of litmus milk (Table 1). In the work of 
Ayad et al. (2004), it was indicated that most strains of 
L. plantarum isolated from different sources showed 
a slow acidification rate. The strain of human origin, 
TMF55, was a fast acidifying culture and produced 
0.810 mmol/l of lactic acid (Table 1). 
Survival in simulated gastrointestinal condition  
(gastric and bile salts test)
Before reaching the intestinal tract, probiotic bac-
teria must pass through the stomach where the pH 
can be as low as 1.5 to 2 (Dunne et al., 2001). This 
acid tolerance helps Lactobacilli to reach the small 
intestine and colon and thus contributes in balanc-
ing the intestinal microflora. Comparing the sur-
vival of tested strains in a low pH of 2.5, a generally 
lower survival of isolates from fermented vegetables 
in relation to intestinal isolates was observed (Fig. 
1). Lactobacilli of intestinal origin are considered 
intrinsically resistant to acid environments and are 
often employed in fermented foods as probiotics 
(Tannock, 2004). However, different strains of L. 
plantarum were found to show a high tolerance to 
the acid condition (pH 2.0) and bile salts. This was 
observed both for the strains isolated from intesti-
nal samples and for those that were isolated from 
fermented foods (De Vries et al., 2006). Our study 
revealed that the strains from fermented vegetables 
could survive under simulated gastric conditions 
but in a lower number (with a loss of viability rang-
ing from 2.0±0.2 to 3.85±0.5 log 10 CFU ml-1) than 
the strains from human sources (Fig. 1). Acid tol-
erance of bacteria is important not only for with-
standing gastric conditions, but also for their use as 
dietary adjuncts. It enables the strains to survive for 
longer periods in acid carrier foods, such as yogurt, 
without a large reduction of viable cells (Minelli et 
al., 2004).
Afterwards the plant and human strains were 
tested for their resistance to simulated duodenal 
conditions (0.4% bile salts and 0.2% pancreatin). Bile 
tolerance is considered one of the important proper-
ties required for high survival and probiotic activity. 
Bile plays an essential role in lipid digestion. It emul-
sifies and solubilizes lipids and functions as a biolog-
ical detergent (Begley at al., 2006). The antimicrobial 
nature of bile is mainly because of its detergent prop-
erty, which dissolves bacterial membranes. There is 
considerable evidence that upon the deconjugation 
of conjugated bile salts in the intestine, the free bile 
acids are toxic for Gram-positive and Gram-negative 
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microorganisms, which is one of the antagonistic 
mechanisms against pathogens in the intestine.
All lactobacilli from fermented vegetables showed 
high tolerance to 0.4% of bile and 0.2% of pancrea-
tin with a loss of viability ranging from 0.22±0.1 to 
2.6±0.6 log 10 CFU ml-1 (Fig. 1). Some tested human 
strains showed a lower bile tolerance than the plant 
strains, with a loss of viability of 3.13±0.8 log 10 CFU 
ml-1 for the TMFEM strain and 3.38±0.9 log 10 CFU 
ml-1 for the TMF55 strain (Fig. 1). Resistance to bile 
salts varies a lot among the lactic acid bacteria species 
and even between strains themselves (Xanthopoulos, 
1997). High tolerance to bile salts has been recently 
reported for some L. plantarum strains isolated from 
fermented olives (Mourad and Nour-Eddine, 2006).
One of the most important characteristic of 
potential probiotic bacteria is protection against 
pathogens in the intestinal tract of the host. In this 
study, Bacillus subtilis, Candida albicans, Salmonel-
la enteritidis, Staphylococcus aureus, Escherichia coli 
and Listeria monocytogenes were used as the test 
bacteria because they are commonly found as food-
borne pathogens. The results of antimicrobial activ-
ity revealed that lactobacilli from fermented veg-
etables could inhibit most of the tested pathogenic 
bacteria, however at different inhibition levels, as 
shown in Table 2. Most isolates from fermented 
vegetables showed the highest inhibition level on E. 
coli and S. enteritidis with inhibition zones over 9 
mm. However, the strains of human origin demon-
strated greater antimicrobial activity than the plant 
Table 1. Sources of isolation and some technological properties of plant and human strains. 
Plant strains
L. plantarum Source
Growth at Survival at
Growth in
No        milk              litmus milk lactic acid (mmol/l)
15 ºC 30 ºC 45ºC 60ºC coagulation
1. PF1 Fermented beet oot + + - - - ACRb 0,360±0.21c
2. PF2 Sauerkraut + + - - +a ACR 0,720±0.18
3. PF3 Sauerkraut + + - - + ACR 0,648±0.32
4. PF4 Fermented carrots + + - - + ACR 0,612±0.29
5. PF22 Sauerkraut + + - - - ACR 0,351±0.25
6. PF23 Sauerkraut + + - - - ACR 0,360±0.15
7. PF24 Sauerkraut + + - - - ACR 0,315±0.21
8. PF30 Fermented beet root + + - - + ACR 0,540±0.23
9. PF31 Fermented carrots + + - - + ACR 0,540±0.32
10. TP3C Fermented beet root + + - - - ACR 0,315±0.50
11. TP10 Sauerkraut + + - - + ACR 0,540±0.51
12. TP11 Sauerkraut + + - - + ACR 0,450±0.29
Human strains
No L. rhamnosus
1. TMFM Preterm infant + + + + + ACR 0,554±0.23
2. TMFV Preterm infant + + + + + ACR 0,626±0.34
3. TMFEM Preterm infant + + - - + ACR 0,711±0.45
4. TMFEV Preterm infant + + - - + ACR 0,765±0.33
5. TMF37 Preterm infant + + - - + ACR 0,711±0.27
6. TMF48 Preterm infant + + - - + ACR 0,702±0.15
7. TMF55 Preterm infant + + - - + ACR 0,810±0.14
a (+)-coagulation of milk, bA-acidification; C-coagulation; R-reduction; cmean±standard deviation.
COMPARATIVE ANALYSIS OF THE POTENTIAL PROBIOTIC ABILITIES OF LACTOBACILLI 1477
isolates, with the highest inhibitory activity against 
S. enteritidis and L. monocytogenes (Table 2). The 
human isolates demonstrated a lack of inhibitory 
activity only against C. albicans (Table 2). The anti-
microbial activity of the tested bacteria may be due 
to the production of organic acid that lowered the 
pH of the medium. The probiotic bacteria may also 
have produced hydrogen peroxide, bacteriocin and 
Table 2 Antimicrobial activity of L. plantarum and L. rhamnosus strains.
L. plantarum
Inhibition zone (mm) of indicator strainsa
B. subtilis ATCC 
6633
C. albicans ATCC 
24433
S. enteritidis ATCC 
31806




L. monocytogenes ATCC 
19115
PF1 8±2.1 - 5±1.7 6±2.2 7±2.2 ¨
PF2 12±1.1 2±1.2 10±1.6 6±1.5 12±2.4 6±1.9
PF3 7±1.4 5±2.2 9±2.1 5±1.9 10±2.1 7±2.1
PF4 8±0.8 5±1.6 9±2.0 5±1.8 12±1.8 3±2.0
PF22 8±1.7 4±1.8 10±1.6 7±1.5 10±1.7 4±1.1
PF23 7±2.1 2±2.1 7±1.1 10±2.1 10±2.3 8±1.4
PF24 6±2.0 3±2.4 9±1.7 4±2.0 8±0.8 6±1.9
PF30 8±1.5 2±2.1 15±2.1 4±2.4 10±1.7 4±1.3
PF31 5±1.7 4±1.4 10±1.5 5±2.2 10±2.3 4±2.1
TP3C 6±2.1 - 12±1.9 4±1.8 10±2.1 5±2.4
TP10 7±2.1 - 10±2.1 3±0.8 11±2.0 2±1.5
TP11 6±1.6 - 10±2.0 6±2.1 10±1.8 6±1.7
L. rhamnosus 
TMFM 8±0.6 - 20±1.4 4±0.4 8±0.7 25±1.4
TMFV 9±1.2 - 20±0.6 7±1.3 9±1.2 18±1.2
TMFEM 9±1.7 - 10±1.2 7±1.3 9±1.2 23±1.1
TMFEV 11±2.2 - 14±0.8 8±1.2 11±1.3 18±1.4
TMF37 11±0.9 - 27±1.2 8±1.2 11±1.2 25±1.5
TMF48 10±1.2 - 17±1.7 6±1.2 10±1.2 24±1.2
TMF55 7±1.7 - 20±1.4 9±0.9 7±1.1 18±0.3
a, mean±standard deviation;  -, no inhibition zone
Table 3. Antibiotic resistance of plant strains.
Antibiotics
Plant strains
PF1 PF2 PF3 PF4 PF22 PF23 PF24 PF30 PF31 TP3C TP10 TP11
Tetracycline + + + + + + + + + + + +
Chloramphenicol + + ++ + + ++ + + ++ + + +
Streptomycin R R R + + + + + R + + +
Neomycin R R R R R R R R R R R R
Penicillin + + + + ++ + + ++ ++ + ++ +
Ampicillin ++ ++ ++ + ++ + + + + + + +
Kanamycin R R R R R R R R R R R R
Trimethoprim  
sulfamethoxazole + + + + R R + + + + R R
Vancomycin R R R R R R R R R R R R
Rifampicin + + + + + + + + + + + +
Gentamicin + + + + + + + + + + + +
Doxycycline + + + + + + + + + + + +
++: sensitive – with halo of inhibition >10mm; +:  moderately sensitive– with halo of inhibition 5-10 mm; R: resistant – with halo of 
inhibition <5mm
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antibacterial compounds or competed for nutrients 
(Šušković et al., 2010).Th e diff erence in antagonis-
tic activity among the tested lactobacilli is probably 
due to the diff erent intrinsic factors induced by the 
diff erent origins.
Th e widespread use of antibiotics for therapeutic 
and prophylactic purposes and for health promotion 
in animal husbandry has resulted in an increased 
number of antibiotic resistant bacteria and most an-
tibiotics became ineff ective (Radulović et al., 2012). 
Th erefore, the antibiotic susceptibility of potential 
probiotic bacteria is one of the crucial criteria for the 
safe application of probiotics in human consump-
tion since bacteria used as probiotics may serve as 
hosts of antibiotic resistance genes, which can be 
transferred to pathogenic bacteria. All strains from 
fermented vegetables showed resistance to kanamy-
cin, vancomycin and neomycin, whereas strains PF1, 
PF2, PF3 and PF31 were resistant to streptomycin as 
shown in Table 3.
Vancomycin is an antibiotic that inhibits the 
synthesis of peptidoglycan, which is the main com-
ponent of bacterial cell wall. Salminen et al. (1998) 
Table 4. Antibiotic resistance of human strains.
Antibiotics
Human strains
TMFM TMFV TMFEM TMFEV TMF37 TMF48 TMF55
Tetracycline  + ++ ++ ++ ++ + ++
Chloramphenicol + ++ ++ ++ ++ + +
Streptomycin R + + + ++ + R
Neomycin R R R R R R R
Penicillin + ++ + + ++ + R
Ampicillin R + + + + + R
Kanamycin R R R R R R R
Trimethoprim + 
Sulfamethoxazole R R R R R R R
Vancomycin R R R R R R R
Rifampicin + + ++ ++ + + +
Gentamicin + + + + + + +
Doxycycline ++ ++ ++ ++ ++ ++ +
Antibiotics TMFM TMFV TMFEM TMFEV TMF37 TMF48 TMF55
++: sensitive – with halo of inhibition >10mm; +:  moderately sensitive– with halo of inhibition 5-10 mm; R: resistant – with halo of 
inhibition <5mm
Fig. 2. Survival of plant and human strains in simulated intesti-
nal conditions (0.4 % bile salts, 0.2 % pancreatin).Fig. 1.  Survival of plant and human strains in simulated gastric 
condition (pH 2.5, 0.3 % pepsin).
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reported that resistance to vancomycin is commonly 
found in the genera Lactobacillus. In addition, the re-
sistance to aminoglycosides, kanamycin, gentamicin 
and streptomycin was probably a natural feature of 
lactobacilli (Hummel et al., 2007)
The isolates from fermented vegetables were 
susceptible to β-lactam antibiotics, ampicillin and 
penicillin, as well as to the protein synthesis inhibi-
tor, chloramphenicol, which is in accordance with 
Kheadr et al. (2004). For trimethoprim-sulfamethox-
azole, all human isolates showed resistance, whereas 
most isolates from plant materials were susceptible 
to this antibiotic (Table 4). 
Resistance of tested strains to trimethoprim was 
considered to be due to a trimethoprim-insensitive 
dehydrofolate reductase (Huovinen, 1987). In addi-
tion, two strains from human sources (TMFM and 
TMF55) showed resistance to penicillin, while all 
strains from fermented vegetables were susceptible to 
this drug (Table 4). From these results it can be gen-
erally concluded that the intestinal isolates showed 
a higher resistance to antibiotics than the isolates 
from fermented vegetables. However, this situation 
is not unusual when considering the fact that the gas-
trointestinal tract of newborns is inoculated with the 
mother’s microflora. 
The differences in antibiotic susceptibility of 
lactobacilli from different origins indicated the role 
of sources of bacterial isolation that might have an 
influence on the genetic level of their antibiotic re-
sistance.
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